Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

Considering the results obtained so far with commercially available ICTs, it is noteworthy that serology-based results commonly indicate helminth exposure but not necessarily active infection, as ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

Over two million schoolage children between five and 14 years have been targeted for a deworming exercise scheduled from ...

We're about to dive into the world of parasitology, taking a close look at one of the most common parasitic worms infecting ...

Keywords: Innate immunity, Type 2 immune responses, Th2 cells, Eosinophils, Basophils, Mast cells, Helminth infections, Wound healing, Immunoregulatory pathways ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

Fox, J.G. et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nature Med. 6, 536–542 (2000).

They’re ever-present, especially when it comes to skin infections,” says Inclan-Rico ... MrgprA3 neurons drive cutaneous immunity against helminths through selective control of myeloid-derived IL-33.

In our clinics, we consider 6% or higher elevated. Eosinophils typically rise in response to helminthic infections, including roundworms, tapeworms, and flukes. So, while this can serve as a cheap ...

The causes of intestinal infections vary widely and can include ... Dr Makwana highlights the combined action of papaya seeds: "With anti-helminthic drugs, one often needs to provide a mild ...